Aran D, Looney AP, Liu L, Wu E, Fong V, Hsu A, Chak S, Naikawadi RP, Wolters PJ, Abate AR et al (2019) Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol 20:163–172

Article  PubMed  PubMed Central  Google Scholar 

Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI, Ostrand-Rosenberg S, Hedrick CC et al (2018) Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med 24:541–550

Article  PubMed  PubMed Central  Google Scholar 

Cavassani KA, Meza RJ, Habiel DM, Chen JF, Montes A, Tripathi M, Martins GA, Crother TR, You S, Hogaboam CM et al (2018) Circulating monocytes from prostate cancer patients promote invasion and motility of epithelial cells. Cancer Med 7:4639–4649

Article  PubMed  PubMed Central  Google Scholar 

Chaudhary K, Poirion OB, Lu L, Garmire LX (2018) Deep learning-based Multi-omics Integration robustly predicts survival in Liver Cancer. Clin Cancer Res 24:1248–1259

Article  PubMed  Google Scholar 

Chen S, Zhu G, Yang Y, Wang F, Xiao YT, Zhang N, Bian X, Zhu Y, Yu Y, Liu F et al (2021) Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. Nat Cell Biol 23:87–98

Article  PubMed  Google Scholar 

Croucher PI, McDonald MM, Martin TJ (2016) Bone metastasis: the importance of the neighbourhood. Nat Rev Cancer 16:373–386

Article  PubMed  Google Scholar 

David-Beabes GL, Overman MJ, Petrofski JA, Campbell PA, de Marzo AM, Nelson WG (2000) Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity. Int J Oncol 17:1077–1086

PubMed  Google Scholar 

Desai K, McManus JM, Sharifi N (2021) Hormonal therapy for prostate Cancer. Endocr Rev 42:354–373

Article  PubMed  PubMed Central  Google Scholar 

Efstathiou E, Titus M, Wen S, Hoang A, Karlou M, Ashe R, Tu SM, Aparicio A, Troncoso P, Mohler J et al (2015) Molecular characterization of enzalutamide-treated bone metastatic castration-resistant prostate cancer. Eur Urol 67:53–60

Article  PubMed  Google Scholar 

Friedman J, Hastie T, Tibshirani R (2010) Regularization paths for generalized Linear models via Coordinate Descent. J Stat Softw 33:1–22

Article  PubMed  PubMed Central  Google Scholar 

Fu X, Wang Z (2024) DHCR24 in Tumor diagnosis and treatment: a Comprehensive Review. Technol Cancer Res Treat 23:15330338241259780

Article  PubMed  PubMed Central  Google Scholar 

Fu S, Liu T, Lv C, Fu C, Zeng R, Kakehi Y, Kulkarni P, Getzenberg RH, Zeng Y (2020) Stromal-epithelial interactions in prostate cancer: overexpression of PAGE4 in stromal cells inhibits the invasive ability of epithelial cells. J Cell Biochem 121:4406–4418

Article  PubMed  Google Scholar 

Gao M, Guo L, Wang H, Huang J, Han F, Xiang S, Wang J (2020) Orphan nuclear receptor RORγ confers doxorubicin resistance in prostate cancer. Cell Biol Int 44:2170–2176

Article  PubMed  Google Scholar 

Gao R, Bai S, Henderson YC, Lin Y, Schalck A, Yan Y, Kumar T, Hu M, Sei E, Davis A et al (2021) Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes. Nat Biotechnol 39:599–608

Article  PubMed  PubMed Central  Google Scholar 

Garnero P, Buchs N, Zekri J, Rizzoli R, Coleman RE, Delmas PD (2000) Markers of bone turnover for the management of patients with bone metastases from prostate cancer. Br J Cancer 82:858–864

Article  PubMed  PubMed Central  Google Scholar 

Giannareas N, Zhang Q, Yang X, Na R, Tian Y, Yang Y, Ruan X, Huang D, Yang X, Wang C et al (2022) Extensive germline-somatic interplay contributes to prostate cancer progression through HNF1B co-option of TMPRSS2-ERG. Nat Commun 13:7320

Article  PubMed  PubMed Central  Google Scholar 

Gustavsson EK, Zhang D, Reynolds RH, Garcia-Ruiz S, Ryten M (2022) Ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2. Bioinformatics 38:3844–3846

Article  PubMed  PubMed Central  Google Scholar 

Hua G, Liu Y, Li X, Xu P, Luo Y (2014) Targeting glucose metabolism in chondrosarcoma cells enhances the sensitivity to doxorubicin through the inhibition of lactate dehydrogenase-A. Oncol Rep 31:2727–2734

Article  PubMed  Google Scholar 

Huang C, Ou R, Chen X, Zhang Y, Li J, Liang Y, Zhu X, Liu L, Li M, Lin D et al (2021) Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC. J Exp Clin Cancer Res 40:304

Article  PubMed  PubMed Central  Google Scholar 

Huang J, Liu D, Li J, Xu J, Dong S, Zhang H (2023) A 12-gene panel in estimating hormone-treatment responses of castration-resistant prostate cancer patients generated using a combined analysis of bulk and single-cell sequencing data. Ann Med 55:2260387

Article  PubMed  PubMed Central  Google Scholar 

Jiang X, Guo S, Wang S, Zhang Y, Chen H, Wang Y, Liu R, Niu Y, Xu Y (2022) EIF4A3-Induced circARHGAP29 promotes aerobic glycolysis in Docetaxel-resistant prostate Cancer through IGF2BP2/c-Myc/LDHA signaling. Cancer Res 82:831–845

Article  PubMed  Google Scholar 

Jiao S, Subudhi SK, Aparicio A, Ge Z, Guan B, Miura Y, Sharma P (2019) Differences in tumor microenvironment dictate T helper lineage polarization and response to immune checkpoint therapy. Cell 179:1177–1190 e1113

Article  PubMed  Google Scholar 

Kfoury Y, Baryawno N, Severe N, Mei S, Gustafsson K, Hirz T, Brouse T, Scadden EW, Igolkina AA, Kokkaliaris K et al (2021) Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment. Cancer Cell 39:1464–1478e1468

Article  PubMed  PubMed Central  Google Scholar 

Konoshenko M, Laktionov P (2022) The miRNAs involved in prostate cancer chemotherapy response as chemoresistance and chemosensitivity predictors. Andrology 10:51–71

Article  PubMed  Google Scholar 

Kwon OK, Bang IH, Choi SY, Jeon JM, Na AY, Gao Y, Cho SS, Ki SH, Choe Y, Lee JN et al (2023) LDHA Desuccinylase Sirtuin 5 as a Novel Cancer metastatic stimulator in aggressive prostate Cancer. Genomics Proteom Bioinf 21:177–189

Article  Google Scholar 

Lawson DA, Zong Y, Memarzadeh S, Xin L, Huang J, Witte ON (2010) Basal epithelial stem cells are efficient targets for prostate cancer initiation. Proc Natl Acad Sci U S A 107:2610–2615

Article  PubMed  PubMed Central  Google Scholar 

Li C, Ma Y, Fei F, Zheng M, Li Z, Zhao Q, Du J, Liu K, Lu R, Zhang S (2020) Critical role and its underlying molecular events of the plasminogen receptor, S100A10 in malignant tumor and non-tumor diseases. J Cancer 11:826–836

Article  PubMed  PubMed Central  Google Scholar 

Liu J, Zhang C, Zhang T, Chang CY, Wang J, Bazile L, Zhang L, Haffty BG, Hu W, Feng Z (2022a) Metabolic enzyme LDHA activates Rac1 GTPase as a noncanonical mechanism to promote cancer. Nat Metab 4:1830–1846

Article  PubMed  PubMed Central  Google Scholar 

Liu Y, Wang J, Horton C, Yu C, Knudsen B, Stefanson J, Hu K, Stefanson O, Green J, Guo C et al (2022b) Stromal AR inhibits prostate tumor progression by restraining secretory luminal epithelial cells. Cell Rep 39:110848

Article  PubMed  PubMed Central  Google Scholar 

Liu J, Song J, Li C (2023) MYBPC1 is a key regulator for laryngeal carcinoma formation. Anticancer Drugs 34:1–8

Article  PubMed  Google Scholar 

Logothetis C, Morris MJ, Den R, Coleman RE (2018) Current perspectives on bone metastases in castrate-resistant prostate cancer. Cancer Metastasis Rev 37:189–196

Article  PubMed  PubMed Central  Google Scholar 

Mabbott NA, Baillie JK, Brown H, Freeman TC, Hume DA (2013) An expression atlas of human primary cells: inference of gene function from coexpression networks. BMC Genomics 14:632

Article  PubMed  PubMed Central